Literature DB >> 16179417

The aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) genes are not expressed in the rat heart.

P Ye1, C J Kenyon, S M MacKenzie, A S Jong, C Miller, G A Gray, A Wallace, A S Ryding, J J Mullins, M W McBride, D Graham, R Fraser, J M C Connell, E Davies.   

Abstract

Aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) catalyze the production of aldosterone and corticosterone, respectively, in the rat adrenal cortex. Recently, there has been some debate as to whether these corticosteroids are also produced in the hearts of rodents and humans, possibly contributing to the development of hypertrophy and myocardial fibrosis. To investigate this, we have used our established, highly sensitive real-time quantitative RT-PCR method to measure CYP11B1 and CYP11B2 mRNA levels in adrenal and cardiac tissue from several rat models of cardiovascular pathology. We have also studied isolated adult rat ventricular myocytes treated with angiotensin II and ACTH. Total RNA was isolated from the adrenal and cardiac tissue of 1) male Wistar rats with heart failure induced by coronary artery ligation and sham-operated controls; 2) stroke-prone spontaneously hypertensive rats and Wistar Kyoto rats as controls; 3) cyp1a1Ren-2 transgenic rats and Fischer controls; 4) isolated adult Sprague-Dawley ventricular myocytes incubated with 11-deoxycorticosterone (DOC), DOC plus angiotensin II, or DOC plus ACTH. Adrenal CYP11B2 expression was significantly increased in transgenic rats compared with Fischer controls (1.3 x 10(9)+/- 1.2 x 10(9) vs. 2.1 x 10(7) +/- 7.0 x 10(6) copies/microg RNA; P < 0.05). There were no other significant differences in adrenal CYP11B2 or CYP11B1 expression between the model animals and their respective controls. Cardiac CYP11B1 and CYP11B2 mRNA transcript levels from all in vivo and in vitro groups were never greater than 100 copies per microgram total RNA and therefore too low to be detected reproducibly. This suggests that cardiac corticosteroid production is unlikely to be of any physiological or pathological significance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179417     DOI: 10.1210/en.2005-0370

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Hypertension and the expanding role of aldosterone.

Authors:  Scott M Mackenzie; John Connell
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

2.  Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats.

Authors:  Jana P Ball; Maryam Syed; Rodrigo O Marañon; Michael E Hall; Roshan Kc; Jane F Reckelhoff; Licy L Yanes Cardozo; Damian G Romero
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

Review 3.  Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function.

Authors:  Matthew D Taves; Celso E Gomez-Sanchez; Kiran K Soma
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-03       Impact factor: 4.310

Review 4.  The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

Review 5.  Is the mineralocorticoid receptor a potential target for stroke prevention?

Authors:  Jessica M Osmond; Christine' S Rigsby; Anne M Dorrance
Journal:  Clin Sci (Lond)       Date:  2008-01       Impact factor: 6.124

6.  Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor.

Authors:  Eric E Essick; Flora Sam
Journal:  Int J Hypertens       Date:  2011-05-22       Impact factor: 2.420

7.  Effects of ACTH, dexamethasone, and adrenalectomy on 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat central nervous system.

Authors:  Ping Ye; Christopher J Kenyon; Scott M Mackenzie; Katherine Nichol; Jonathan R Seckl; Robert Fraser; John M C Connell; Eleanor Davies
Journal:  J Endocrinol       Date:  2008-02       Impact factor: 4.286

Review 8.  Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone.

Authors:  N Muñoz-Durango; A Vecchiola; L M Gonzalez-Gomez; F Simon; C A Riedel; C E Fardella; A M Kalergis
Journal:  Biomed Res Int       Date:  2015-09-10       Impact factor: 3.411

9.  Rapid induction of aldosterone synthesis in cultured neonatal rat cardiomyocytes under high glucose conditions.

Authors:  Masami Fujisaki; Tomohisa Nagoshi; Tetsuo Nishikawa; Taro Date; Michihiro Yoshimura
Journal:  Biomed Res Int       Date:  2013-10-28       Impact factor: 3.411

Review 10.  Interfering with mineralocorticoid receptor activation: the past, present, and future.

Authors:  Anne M Dorrance
Journal:  F1000Prime Rep       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.